Drachman David J 4
4 · AtriCure, Inc. · Filed May 22, 2012
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Drachman David J
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2012-05-18$1.33/sh+5,343$7,106→ 497,609 total - Sale
Common Stock
2012-05-22$8.24/sh−33,841$278,850→ 458,425 total - Sale
Common Stock
2012-05-18$8.19/sh−5,343$43,759→ 492,266 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-18−5,343→ 24,553 totalExercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (5,343 underlying)
Footnotes (4)
- [F1]This transaction was executed in multiple trades at prices ranging from $8.10 to $8.29 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]The Reporting Person intends to apply proceeds from the disposition of these shares to the payment of taxes and other costs incurred in connection with the exercise of options reported separately.
- [F3]This transaction was executed in multiple trades at prices ranging from $8.20 to $8.40 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]These options were granted on October 14, 2002 and are exercisable cumulatively at a rate of 25% per annum beginning on October 14, 2003 (one year from grant date).